Orientbio Inc. (002630)
KRX SM KRX SM Primary Summary
Orientbio Inc. (002630) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Orientbio Inc. ever had a stock split?
Orientbio Inc. Profile
| Biotechnology Industry | Healthcare Sector | Mr. Jae-Jin Chang CEO | KRX SM Exchange | KR7002630002 ISIN |
| KR Country | - Employees | 30 Mar 2000 Last Dividend | 12 Dec 2018 Last Split | - IPO Date |
Overview
ORIENT BIO Inc. is a distinguished entity in the bio-industry within South Korea, marking its significance through an extensive portfolio in the production of laboratory animals and the provision of assorted research environment equipment. Established in 1959, initially under the name Orient Co., Ltd., the company transitioned to its current identity, ORIENT BIO Inc., in 2005 to better reflect its dedicated focus in the bio-industry sector. The company's headquarters are strategically positioned in Seongnam-si, South Korea, from where it continues to innovate and contribute significantly to the bio-research domain.
Products and Services
- Laboratory Animals
ORIENT BIO Inc. holds a prominent position in the production of high-quality laboratory animals, catering to a wide array of research purposes across the biomedical field. The emphasis on producing genetically stable and well-documented animal models underlines the company's commitment to support groundbreaking scientific research.
- Research Environment Equipment
Complementing its laboratory animal production, ORIENT BIO Inc. offers an extensive assortment of equipment tailored for the research environment. This comprehensive range covers the needs for creating and maintaining optimal conditions for bio-research, ensuring that every aspect of the experimental setup adheres to the highest standards of quality and reliability.
